A cross-sectional study of docosahexaenoic acid status and cognitive outcomes in females of reproductive age with phenylketonuria
Sarah H. L. Yi
Nutrition & Health Sciences Program of the Graduate Division of Biological & Biomedical Sciences, Emory University, Atlanta, GA, USA
Search for more papers by this authorJulie A. Kable
Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA
Search for more papers by this authorMarian L. Evatt
Department of Veterans Affairs Medical Center, Atlanta, GA, USA
Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA
Search for more papers by this authorCorresponding Author
Rani H. Singh
Nutrition & Health Sciences Program of the Graduate Division of Biological & Biomedical Sciences, Emory University, Atlanta, GA, USA
Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, USA
2165 N. Decatur Road, Decatur, GA, 30033 USA
Telephone: +1-404-7788519, Fax: +1-404-7788562, [email protected]
Search for more papers by this authorSarah H. L. Yi
Nutrition & Health Sciences Program of the Graduate Division of Biological & Biomedical Sciences, Emory University, Atlanta, GA, USA
Search for more papers by this authorJulie A. Kable
Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA
Search for more papers by this authorMarian L. Evatt
Department of Veterans Affairs Medical Center, Atlanta, GA, USA
Department of Neurology, Emory University School of Medicine, Atlanta, GA, USA
Search for more papers by this authorCorresponding Author
Rani H. Singh
Nutrition & Health Sciences Program of the Graduate Division of Biological & Biomedical Sciences, Emory University, Atlanta, GA, USA
Department of Human Genetics, Emory University School of Medicine, Atlanta, GA, USA
2165 N. Decatur Road, Decatur, GA, 30033 USA
Telephone: +1-404-7788519, Fax: +1-404-7788562, [email protected]
Search for more papers by this authorCommunicated by: John H. Walter
References to electronic databases: Phenylketonuria (PKU; OMIM 261600), phenylalanine hydroxylase (PAH; EC 1.14.16.1), docosahexaenoic acid (DHA; PubChem ID 445580)
Competing interest: None declared.
Electronic Supplementary Material:
The online version of this article (doi:10.1007/s10545-011-9277-9) contains supplementary material, which is available to authorized users.
Abstract
Diet therapy for phenylketonuria (PKU) requires restricted phenylalanine (Phe) intake, with the majority of protein and other nutrients coming from synthetic medical food. The fatty acid docosahexaenoic acid (DHA) is important in brain development and function; however, there are reports of low blood DHA concentrations in people treated for PKU. Although the implications of this low blood DHA are unclear, subtle cognitive deficits have been reported in those treated early and continuously for PKU. For this study, we investigated the relationship between DHA status and cognitive performance in 41 females 12 years and older with PKU. Participants were attending the baseline visit of a research-based camp or a supplementation trial. We assessed the domains of verbal ability, processing speed, and executive function using standardized tests, and the proportions of DHA in plasma and red blood cell (RBC) total lipids using gas chromatography/mass spectrometry. Percent plasma and RBC total lipid DHA were significantly lower in the participants compared with laboratory controls (P < .001), and participants consumed no appreciable DHA according to diet records. Plasma and RBC DHA both negatively correlated with plasma Phe (P < .02), and performance on the verbal ability task positively correlated with RBC DHA controlling for plasma Phe (R = .32, P = .03). The relationship between DHA and domains related to verbal ability, such as learning and memory, should be confirmed in a controlled trial. Domains of processing speed and executive function may require a larger sample size to clarify any association with DHA.
Supporting Information
| Filename | Description |
|---|---|
| jimd0455-sup-0001.docapplication/doc, 59.5 KB | (DOC 59 kb) |
Please note: The publisher is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.
References
- Acosta PB, Yannicelli S, Singh R, et al (2001) Intake and blood levels of fatty acids in treated patients with phenylketonuria. J Pediatr Gastroenterol Nutr, 33: 253–259, .
10.1002/j.1536-4801.2001.tb07453.x Google Scholar
- Agostoni C, Massetto N, Biasucci G, et al (2000) Effects of long-chain polyunsaturated fatty acid supplementation on fatty acid status and visual function in treated children with hyperphenylalaninemia. J Pediatr, 137: 504–509, .
- Agostoni C, Harvie A, McCulloch DL, et al (2006) A randomized trial of long-chain polyunsaturated fatty acid supplementation in infants with phenylketonuria. Dev Med Child Neurol, 48: 207–212, .
- Arbuckle LD, MacKinnon MJ, Innis SM (1994) Formula 18: 2(n-6) and 18:3(n-3) content and ratio influence long-chain polyunsaturated fatty acids in the developing piglet liver and central nervous system. J Nutr, 124: 289–298.
- Bazan NG (2009) Cellular and molecular events mediated by docosahexaenoic acid-derived neuroprotectin D1 signaling in photoreceptor cell survival and brain protection. Prostaglandins Leukot Essent Fatty Acids, 81: 205–211, .
- Beblo S, Reinhardt H, Muntau AC, Mueller-Felber W, Roscher AA, Koletzko B (2001) Fish oil supplementation improves visual evoked potentials in children with phenylketonuria. Neurology, 57: 1488–1491.
- Beblo S, Reinhardt H, Demmelmair H, Muntau AC, Koletzko B (2007) Effect of fish oil supplementation on fatty acid status, coordination, and fine motor skills in children with phenylketonuria. J Pediatr, 150: 479–484, .
- Bickel H, Gerrard J, Hickmans EM (1953) Influence of phenylalanine intake on phenylketonuria. Lancet, 265: 812–813, .
- Birch EE, Garfield S, Castaneda Y, Hughbanks-Wheaton D, Uauy R, Hoffman D (2007) Visual acuity and cognitive outcomes at 4 years of age in a double-blind, randomized trial of long-chain polyunsaturated fatty acid-supplemented infant formula. Early Hum Dev, 83: 279–284, .
- Blank C, Neumann MA, Makrides M, Gibson RA (2002) Optimizing DHA levels in piglets by lowering the linoleic acid to alpha-linolenic acid ratio. J Lipid Res, 43: 1537–1543, .
- Brumm VL, Azen C, Moats RA, et al (2004) Neuropsychological outcome of subjects participating in the PKU adult collaborative study: a preliminary review. J Inherit Metab Dis, 27: 549–566, .
- Carver JD, Benford VJ, Han B, Cantor AB (2001) The relationship between age and the fatty acid composition of cerebral cortex and erythrocytes in human subjects. Brain Res Bull, 56: 79–85, .
- Cerone R, Schiaffino MC, Di Stefano S, Veneselli E (1999) Phenylketonuria: diet for life or not?. Acta Paediatr, 88: 664–666, .
- Channon S, Mockler C, Lee P (2005) Executive functioning and speed of processing in phenylketonuria. Neuropsychology, 19: 679–686, .
- Channon S, Goodman G, Zlotowitz S, Mockler C, Lee PJ (2007) Effects of dietary management of phenylketonuria on long-term cognitive outcome. Arch Dis Child, 92: 213–218, .
- Cockburn F, Clark BJ, Caine EA, et al (1996) Fatty acids in the stability of neuronal membrane: relevance to PKU. Int Pediatr, 11: 56–60.
- deGroot RH, Adam J, Jolles J, Hornstra (2004) Alpha-linolenic acid supplementation during human pregnancy does not effect cognitive functioning. Prostaglandins Leukot Essent Fatty Acids, 70: 41–47, .
10.1016/j.plefa.2003.08.004 Google Scholar
- deGroot RH, Hornstra G, Jolles J (2007) Exploratory study into the relation between plasma phospholipid fatty acid status and cognitive performance. Prostaglandins Leukot Essent Fatty Acids, 76: 165–172, .
- Delis DC, Kaplan E, Kramer JH (2001) Delis-Kaplan Executive Function System: Technical Manual, San Antonio, TX: The Psychological Corporation.
- DeRoche K, Welsh M (2008) Twenty-five years of research on neurocognitive outcomes in early-treated phenylketonuria: intelligence and executive function. Dev Neuropsychol, 33: 474–504, .
- Dunn LM, Dunn LM (1997) Examiner's Manual for the Peabody Picture Vocabulary Test–Third Edition (PPVT-III), Circle Pines, MN: American Guidance Service.
- Engstrom K, Saldeen AS, Yang B, Mehta JL, Saldeen T (2009) Effect of fish oils containing different amounts of EPA, DHA, and antioxidants on plasma and brain fatty acids and brain nitric oxide synthase activity in rats. Ups J Med Sci, 114: 206–213, .
- Feldmann R, Denecke J, Grenzebach M, Weglage J (2005) Frontal lobe-dependent functions in treated phenylketonuria: blood phenylalanine concentrations and long-term deficits in adolescents and young adults. J Inherit Metab Dis, 28: 445–455, .
- Fisch RO, Chang PN, Weisberg S, Guldberg P, Guttler F, Tsai MY (1995) Phenylketonuric patients decades after diet. J Inherit Metab Dis, 18: 347–353, .
10.1007/BF00710427 Google Scholar
- Galli C, Agostoni C, Mosconi C, Riva E, Salari PC, Giovannini M (1991) Reduced plasma C-20 and C-22 polyunsaturated fatty acids in children with phenylketonuria during dietary intervention. J Pediatr, 119: 562–567, .
- Holte LL, Peter SA, Sinnwell TM, Gawrisch K (1995) 2 H nuclear magnetic resonance order parameter profiles suggest a change of molecular shape for phosphatidylcholines containing a polyunsaturated acyl chain. Biophys J, 68: 2396–2403, .
- Infante JP, Huszagh VA (2001) Impaired arachidonic (20: 4n-6) and docosahexaenoic (22:6n-3) acid synthesis by phenylalanine metabolites as etiological factors in the neuropathology of phenylketonuria. Mol Genet Metab, 72: 185–198, .
- Jenski LJ, Stillwell W (1999) Role of docosahexaenoic acid in determining membrane structure and function. In: D Mostofsky, S Yehuda, N Salem, eds. Fatty acids: physiological and behavioral functions, Totowa: Human Press, 41–62.
- Jiang L, Shi Y, Long Y, Yang Z (2009) The influence of orally administered docosahexaenoic acid on monoamine neurotransmitter, nerve growth factor, and brain-derived neurotrophic factor in aged mice. Pharm Biotechnol (Formerly Int. J. Pharmacogn), 47: 584–591.
- Koletzko B, Beblo S, Demmelmair H, Muller-Felber W, Hanebutt FL (2009) Does dietary DHA improve neural function in children? Observations in phenylketonuria. Prostaglandins Leukot Essent Fatty Acids, 81: 159–164, .
- Kris-Etherton PM, Taylor DS, Yu-Poth S, et al (2000) Polyunsaturated fatty acids in the food chain in the United States. Am J Clin Nutr, 71: 179S–188S.
- Lagerstedt SA, Hinrichs DR, Batt SM, Magera MJ, Rinaldo P, McConnell JP (2001) Quantitative determination of plasma c8-c26 total fatty acids for the biochemical diagnosis of nutritional and metabolic disorders. Mol Genet Metab, 73: 38–45, .
- LaVoie SM, Harding CO, Gillingham MB (2009) Normal Fatty Acid Concentrations in Young Children With Phenylketonuria. Top Clin Nutr, 24: 333–340.
10.1097/TIN.0b013e3181c621fa Google Scholar
- Liou YA, King DJ, Zibrik D, Innis SM (2007) Decreasing linoleic acid with constant alpha-linolenic acid in dietary fats increases (n-3) eicosapentaenoic acid in plasma phospholipids in healthy men. J Nutr, 137: 945–952.
- Llorente AM, Jensen CL, Voigt RG, Fraley JK, Berretta MC, Heird WC (2003) Effect of maternal docosahexaenoic acid supplementation on postpartum depression and information processing. Am J Obstet Gynecol, 188: 1348–1353, .
- Mazer LM, Yi SH, Singh RH (2010) Docosahexaenoic acid status in females of reproductive age with maple syrup urine disease. J Inherit Metab Dis, 33 (2): 121–7.
10.1007/s10545-010-9066-x Google Scholar
- McGrew KS, Woodcock RW (2001) Woodcock-Johnson III Technical Manual, Itasca, IL: Riverside.
- Moseley K, Koch R, Moser AB (2002) Lipid status and long-chain polyunsaturated fatty acid concentrations in adults and adolescents with phenylketonuria on phenylalanine-restricted diet. J Inherit Metab Dis, 25: 56–64, .
- Moyle JJ, Fox AM, Arthur M, Bynevelt M, Burnett JR (2007) Meta-Analysis of Neuropsychological Symptoms of Adolescents and Adults with PKU. Neuropsychol Rev, 17: 91–101, .
- Moyle JJ, Fox AM, Bynevelt M, Arthur M, Burnett JR (2007) A neuropsychological profile of off-diet adults with phenylketonuria. J Clin Exp Neuropsychol, 29: 436–441, .
- National Institutes of Health Consensus Development Panel (2001) National Institutes of Health Consensus Development Conference Statement: phenylketonuria: screening and management, October 16-18, 2000. Pediatrics, 108: 972–982, .
- NIST Chemistry WebBook. 2008. http://webbook.nist.gov. Accessed January 16, 2010.
- Paine RS (1957) The variability in manifestations of untreated patients with phenylketonuria (phenylpyruvic aciduria). Pediatrics, 20: 290–302.
- Pawlosky RJ, Hibbeln JR, Novotny JA, Salem NJr (2001) Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humans. J Lipid Res, 42: 1257–1265.
- Poge AP, Baumann K, Muller E, Leichsenring M, Schmidt H, Bremer HJ (1998) Long-chain polyunsaturated fatty acids in plasma and erythrocyte membrane lipids of children with phenylketonuria after controlled linoleic acid intake. J Inherit Metab Dis, 21: 373–381, .
- Rosell MS, Lloyd-Wright Z, Appleby PN, Sanders TA, Allen NE, Key TJ (2005) Long-chain n-3 polyunsaturated fatty acids in plasma in British meat-eating, vegetarian, and vegan men. Am J Clin Nutr, 82: 327–334.
- Ryan AS, Nelson EB (2008) Assessing the effect of docosahexaenoic acid on cognitive functions in healthy, preschool children: a randomized, placebo-controlled, double-blind study. Clin Pediatr (Phila), 47: 355–362, .
- Salem NJr, Litman B, Kim HY, Gawrisch K (2001) Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids, 36: 945–959, .
- Schrank FA, McGrew KS, Woodcock RW (2001) Technical Abstract (Assessment Service Bulletin No. 2), Riverside, Itasca, IL.
- Slocum RH, Cummings A (1991) Amino acid analysis of physiological samples. In: F Hommos, ed. Techniques in diagnostic human biochemical genetics, New York: Wiley Liss.
- Spector AA (2001) Plasma free fatty acid and lipoproteins as sources of polyunsaturated fatty acid for the brain. J Mol Neurosci, 16: 159–165, .
- Stroop JR (1935) Studies of interference in serial verbal reactions. J Exp Psychol, 18: 643–662, .
- vanGool CJ, vanHouwelingen AC, Hornstra G (2000) The essential fatty acid status in phenylketonuria patients under treatment. J Nutr Biochem, 11: 543–547, .
- VanZutphen KH, Packman W, Sporri L, et al (2007) Executive functioning in children and adolescents with phenylketonuria. Clin Genet, 72: 13–18, .
- Waisbren SE, Levy HL (1991) Agoraphobia in phenylketonuria. J Inherit Metab Dis, 14: 755–764, .
- Waisbren SE, Zaff J (1994) Personality disorder in young women with treated phenylketonuria. J Inherit Metab Dis, 17: 584–592, .
- Waisbren SE, Brown MJ, deSonneville LM, Levy HL (1994) Review of neuropsychological functioning in treated phenylketonuria: an information processing approach. Acta Paediatr Suppl, 407: 98–103, .
- Wassall SR, Stillwell W (2008) Docosahexaenoic acid domains: the ultimate non-raft membrane domain. Chem Phys Lipids, 153: 57–63, .
